Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some observations on current and possible future developments in bioequivalency testing.

C T Rhodes1

  • 1Department of Applied Pharmaceutical Sciences, University of Rhode Island, Kingston 02881, USA.

Drug Development and Industrial Pharmacy
|April 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Some studies of the stability of compounded cefazolin ophthalmic solution.

International journal of pharmaceutical compounding·2013
Same author

Thermodynamic analysis of water interaction with excipient films.

Drug development and industrial pharmacy·2001
Same author

Hot-melt coating: water sorption behavior of excipient films.

Drug development and industrial pharmacy·2001
Same author

Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2000
Same author

Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system.

Journal of microencapsulation·2000
Same author

Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres.

Pharmaceutical development and technology·2000
Same journal

Preparation and Characterisation of Pre-Nanoemulsions Encapsulating Multiple Oil-Soluble Active Substances.

Drug development and industrial pharmacy·2026
Same journal

Synergistic Anticancer Potential of Andrographolide and Paclitaxel: A Dose-Reduction Strategy to Minimize Toxicity and Enhance Therapeutic Efficacy.

Drug development and industrial pharmacy·2026
Same journal

Sustainable Nanomaterial Production from Fruit Waste: Green Synthesis of ZnO Nanoparticles for Antioxidant, Antimicrobial, and Therapeutic Applications in Wound Healing and Cancer Therapy.

Drug development and industrial pharmacy·2026
Same journal

Biocompatible and bio-orthogonal surface engineering of inorganic self-assembled nanocrystals for precision drug targeting: a review.

Drug development and industrial pharmacy·2026
Same journal

Next-generation drug delivery for age-related macular degeneration: promise of controlled release formulations.

Drug development and industrial pharmacy·2026
Same journal

Design, optimization, and evaluation of ferulic acid-loaded cubosomal cream for enhanced topical delivery and anti-hyperpigmentation efficacy.

Drug development and industrial pharmacy·2026
See all related articles

Bioequivalency studies are evolving, shifting from quality control to clinical relevance. While simplification is possible, changes require public discussion and consistent, neutral application of standards.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Development
  • Regulatory Science

Background:

  • Bioequivalency studies are critical for generic drug approval.
  • Current interpretations increasingly view these studies as clinical indicators.
  • There's a continuous need to refine study designs and interpretations.

Purpose of the Study:

  • To review current trends in bioequivalency study design and interpretation.
  • To explore possibilities for simplifying bioequivalency testing procedures.
  • To emphasize the importance of careful consideration and stakeholder involvement in procedural changes.

Main Methods:

  • Review of current literature and trends in bioequivalency study design.
  • Analysis of the evolving role of bioequivalency studies in drug evaluation.

Related Experiment Videos

  • Discussion of potential modifications to existing bioequivalency testing protocols.

    • Main Results:

    • Bioequivalency studies are increasingly recognized for their clinical relevance.
    • Opportunities exist to simplify bioequivalency testing methodologies.
    • Procedural changes necessitate thorough public discourse among stakeholders.

    Conclusions:

    • Future modifications to bioequivalency testing require careful public discussion involving regulators, academia, and industry.
    • Bioequivalency standards must maintain internal consistency.
    • Application of bioequivalency standards should be politically neutral to ensure scientific integrity.